The neuroprotection market in North America is set to stay robust through 2031, supported by well-developed healthcare infrastructure, a higher incidence of neurodegenerative diseases, an older population, and continued commitment to neuroscience research. As per The Insight Partners, the region accounted for the largest portion of the global market in 2023. The presence of established life...